Fundraising Fox

Obstetrx

Wilsonville, US · Founded 2017 · Delaware corporation

Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.

Founders & leadership

AB
Andrew BarofskyNamed on SEC filing
KG
Kenton GregoryNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 1 round · 2021

$1.1MraisedAug 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew BarofskyExecutive Officer, Director
  • Kenton GregoryDirector
Offering amount
$3M
Amount sold
$1.1M
Minimum investment
$500K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Obstetrx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Obstetrx do?
Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.
How much funding has Obstetrx raised?
Obstetrx has disclosed $1.1M raised across 1 round.
Where is Obstetrx headquartered?
Obstetrx is headquartered in Wilsonville, US.